Ophthalmology Doctors in Hatboro, PA Accepting Medicare
7 Ophthalmology doctors found. Showing 1 - 7
 Dr. Francis J Clark, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 331 N York Rd, Hatboro, PA 19040 Phone: 215-672-4300 Fax: 215-672-9524 |
Dr. Thomas A Armstrong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 345 N York Rd, Hatboro, PA 19040 Phone: 215-672-9030 Fax: 215-672-8099 |
Dr. Avraham N Cohen, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 345 N York Rd, Hatboro, PA 19040 Phone: 215-672-9030 Fax: 215-672-8099 |
Dr. Eric G George, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 345 N York Rd, Hatboro, PA 19040 Phone: 215-672-9030 Fax: 215-672-8099 |
 Maria Patricia Martinez Lehmann, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 331 N York Rd, Hatboro, PA 19040 Phone: 215-672-4300 Fax: 215-542-9609 |
Dr. Daniel V Will, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 345 N York Rd, Hatboro, PA 19040 Phone: 215-672-9030 Fax: 215-672-8099 |
Dr. Cathy A Colt, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 345 N York Rd, Hatboro, PA 19040 Phone: 215-672-9030 Fax: 215-672-8099 |
News Archive
House expanding inquiry of health insurance rate hikes
The House Committee on Energy and Commerce, which held a hearing last week on a California insurer's rate increases, is expanding its investigation.
ImmunoGen presents first findings aimed at optimizing dosage of IMGN853 product candidate
ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the first findings from Company research aimed at optimizing the dosing of its IMGN853 product candidate.
History of child abuse linked to alcohol abuse in women
Women who suffered sexual or physical abuse as children are more likely to abuse alcohol than are others, according to a new study of 3,680 women.
Insulin interaction map could lead to new therapeutic targets for type 2 diabetes
A team led by scientists at The Scripps Research Institute has created the first comprehensive roadmap of the protein interactions that enable cells in the pancreas to produce, store and secrete the hormone insulin. The finding makes possible a deeper scientific understanding of the insulin secretion process—and how it fails in insulin disorders such as type 2 diabetes.
› Verified 6 days ago